Metraipolis › archive › dc_c110eed41966

Bridging mechanism and clinic: unlocking the full potential of oncolytic virus-based immunotherapy — Europe PMC PMID:41917920

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41917920
DOI
10.1186/s12943-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-03T14:36:51.161Z
SHA-256 of the archived text
6bda584556eaf2877ee88e7042cb0ee5ad4651b68d97dbf100cc3b14fd08dbab
Stable URL of this page
https://metraipolis.com/documento/dc_c110eed41966

How to cite

Bridging mechanism and clinic: unlocking the full potential of oncolytic virus-based immunotherapy — Europe PMC PMID:41917920 — Europe PMC (en), https://europepmc.org/article/MED/41917920 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c110eed41966 (Metraipolis archive dc_c110eed41966, sha256 6bda584556eaf2877ee88e7042cb0ee5ad4651b68d97dbf100cc3b14fd08dbab)
BibTeX
@misc{dcc110eed41966,
  title = {Bridging mechanism and clinic: unlocking the full potential of oncolytic virus-based immunotherapy — Europe PMC PMID:41917920},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41917920},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c110eed41966; sha256 6bda584556eaf2877ee88e7042cb0ee5ad4651b68d97dbf100cc3b14fd08dbab},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41917920. Agents can read the archived copy with the MCP tool read_document.